BioFreedom FIM Clinical Trial.

NCT01172119 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

182

Enrollment

INDUSTRY

Sponsor class

Conditions

Treatment Of Stenotic Lesions In Native Coronary Arteries.

Interventions

DEVICE: Biofreedom Drug Eluting Stent
DEVICE: Biofreedom Drug Eluting Stent
DEVICE: Tuxus Liberte Drug Eluting Stent

Sponsor

Biosensors Europe SA